Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?

Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?

Bibliographic Details
Main Authors:	Cobbold, S, Li, X
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
by: Stephen Paul Cobbold, et al.
Published: (2012-10-01)

Translating tolerogenic therapies to the clinic - where do we stand?
by: Issa, F, et al.
Published: (2012)

Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
by: Eros Marín, et al.
Published: (2018-02-01)

Clinical Microbiology: where do we stand?
by: Alkiviadis Vatopoulos
Published: (2024-06-01)

Gene therapy for clinical transplantation: where do we stand in 2006?
by: Tan, P, et al.
Published: (2006)

Translating High-Frame-Rate Imaging into Clinical Practice: Where Do We Stand?
by: Popescu Aniela, et al.
Published: (2023-06-01)

Where do we stand on adjuvant melanoma therapy?
by: Ana L. Matos, et al.
Published: (2022-10-01)

The gut microbiota in osteoarthritis: where do we stand and what can we do?
by: Xiaoxia Hao, et al.
Published: (2021-01-01)

Clinical chorioamnionitis: where do we stand now?
by: David Lukanović, et al.
Published: (2023-05-01)

Clinical Proteomics in Mexico: where do we stand?
by: Genaro Patiño-Lopez, et al.
Published: (2017-05-01)

Cancer screening in the aging population: Where do we stand and what can we do?
by: Wei Cao, et al.
Published: (2022-09-01)

Where we do stand on integrity?
by: Abd Razak, Dzulkifli
Published: (2007)

Violence: where do we stand?
by: Wasantha Gunathunga
Published: (2001-12-01)

Where we stand
by: Luigi Colazzo
Published: (2014-09-01)

ColVI myopathies: where do we stand, where do we go?
by: Allamand Valérie, et al.
Published: (2011-09-01)

Clinical trials in India: Where do we stand globally?
by: Sandhiya Selvarajan, et al.
Published: (2013-01-01)

Artificial Intelligence in Senology - Where Do We Stand and What Are the Future Horizons?
by: Alexander Mundinger, et al.
Published: (2024-04-01)

Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
by: Inês Barros, et al.
Published: (2020-10-01)

Bio-inspired computation : where we stand and what’s next
by: Del Ser, Javier, et al.
Published: (2020)

Genomics of Trypanosomatidae: Where We Stand and What Needs to Be Done?
by: Vyacheslav Yurchenko, et al.
Published: (2021-09-01)

Editorial: Personalized medicine—Where do we stand regarding bench to bedside translation?
by: Hanumantha Rao Balaji Raghavendran, et al.
Published: (2023-08-01)

Cell Therapy for Anal Sphincter Incontinence: Where Do We Stand?
by: Alexandre Balaphas, et al.
Published: (2021-08-01)

Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
by: Kenneth Lundstrom
Published: (2023-03-01)

Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?
by: Aikaterini Bakirtzi, et al.
Published: (2023-10-01)

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
by: Roger M. Pallares, et al.
Published: (2022-12-01)

Transplantation tolerance-where do we stand?
by: Waldmann, H
Published: (1999)

Genetics of Keratoconus: Where Do We Stand?
by: Khaled K. Abu-Amero, et al.
Published: (2014-01-01)

Transient hyperphosphatasemia--where do we stand?
by: S Kutílek, et al.
Published: (1999-04-01)

Xenotransplantation: where do we stand in 2016?
by: Gisella L. Yung Puga, et al.
Published: (2017-02-01)

Microbiological surveillance – where do we stand?
by: Ulrike Beilenhoff
Published: (2023-04-01)

Knowledge of Anatomy: Where Do we Stand?
by: Muhammad Saeed, et al.
Published: (2009-12-01)

Knowledge of Anatomy: Where Do we Stand?
by: Muhammad Saeed, et al.
Published: (2009-12-01)

Preventive psychiatry: Where do we stand?
by: Roy Abraham Kallivayalil, et al.
Published: (2017-01-01)

Phytotherapy for Cachexia: Where Do We Stand?
by: Kenny Kuchta, et al.
Published: (2020-07-01)

Myelodysplastic syndromes: Where do we stand?
by: Nitin Sood, et al.
Published: (2016-01-01)

Artificial intelligence: Where do we stand?
by: Alok Chandra Agrawal
Published: (2021-01-01)

Maximizing neuroprotection: where do we stand?
by: Kuffler DP
Published: (2012-04-01)

Inducing a tolerogenic microenvironment within tissues
by: Cobbold, S
Published: (2011)

Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here
by: Cristina Vassalle, et al.
Published: (2020-06-01)

Assessment of three "who" patient safety solutions: Where do we stand and what can we do?
by: Sheida Banihashemi, et al.
Published: (2015-01-01)